These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 23651959)

  • 1. Can catheter-based renal denervation reduce frequency of hospitalization in patients who have resistant hypertension and heart failure with reduced ejection fraction?
    Güvendi Sengor B; Yilmaz C; Keten MF; Zehir R
    Hipertens Riesgo Vasc; 2024; 41(3):198-200. PubMed ID: 38641442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catheter-Based Renal Denervation Ready for the Management of Hypertension: Evidence, Challenges, and Perspectives.
    Kario K
    J Am Heart Assoc; 2024 Aug; 13(16):e037099. PubMed ID: 39140342
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of catheter-based renal denervation on renin-aldosterone system, catecholamines, and electrolytes: A systematic review and meta-analysis.
    Yang X; Lin L; Zhang Z; Chen X
    J Clin Hypertens (Greenwich); 2022 Dec; 24(12):1537-1546. PubMed ID: 36321724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of renal sympathetic denervation on ventricular and neural remodeling.
    Wang L; Wei G; Song L; Li C; Zhang F; Yang Y; Lu C
    Herz; 2019 Dec; 44(8):717-725. PubMed ID: 29651618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary vein isolation combined with spironolactone or renal sympathetic denervation in patients with chronic kidney disease, uncontrolled hypertension, paroxysmal atrial fibrillation, and a pacemaker.
    Kiuchi MG; Chen S; Hoye NA; Pürerfellner H
    J Interv Card Electrophysiol; 2018 Jan; 51(1):51-59. PubMed ID: 29264729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary vein isolation alone and combined with renal sympathetic denervation in chronic kidney disease patients with refractory atrial fibrillation.
    Kiuchi MG; Chen S; E Silva GR; Paz LM; Kiuchi T; de Paula Filho AG; Souto GL
    Kidney Res Clin Pract; 2016 Dec; 35(4):237-244. PubMed ID: 27957419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic kidney disease and risk factors responsible for sudden cardiac death: a whiff of hope?
    Kiuchi MG; Mion D
    Kidney Res Clin Pract; 2016 Mar; 35(1):3-9. PubMed ID: 27069851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Term Effects of Renal Sympathetic Denervation on Hypertensive Patients With Mild to Moderate Chronic Kidney Disease.
    Kiuchi MG; Graciano ML; Carreira MA; Kiuchi T; Chen S; Lugon JR
    J Clin Hypertens (Greenwich); 2016 Mar; 18(3):190-6. PubMed ID: 26718019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential role of afferent and efferent renal nerves in the maintenance of early- and late-phase Dahl S hypertension.
    Foss JD; Fink GD; Osborn JW
    Am J Physiol Regul Integr Comp Physiol; 2016 Feb; 310(3):R262-7. PubMed ID: 26661098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal sympathetic denervation in patients with hypertension and chronic kidney disease: does improvement in renal function follow blood pressure control?
    Kiuchi MG; Chen S; Andrea BR; Kiuchi T; Carreira MA; Graciano ML; Lugon JR
    J Clin Hypertens (Greenwich); 2014 Nov; 16(11):794-800. PubMed ID: 25293878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms mediating renal sympathetic nerve activation in obesity-related hypertension.
    Chen W; Leo S; Weng C; Yang X; Wu Y; Tang X
    Herz; 2015 Apr; 40 Suppl 2():190-6. PubMed ID: 24609799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal sympathetic denervation using an irrigated radiofrequency ablation catheter for the management of drug-resistant hypertension.
    Ahmed H; Neuzil P; Skoda J; Petru J; Sediva L; Schejbalova M; Reddy VY
    JACC Cardiovasc Interv; 2012 Jul; 5(7):758-65. PubMed ID: 22814781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal sympathetic denervation as second-line therapy in mild resistant hypertension: a pilot study.
    Kaltenbach B; Franke J; Bertog SC; Steinberg DH; Hofmann I; Sievert H
    Catheter Cardiovasc Interv; 2013 Feb; 81(2):335-9. PubMed ID: 22807098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal denervation: unde venis et quo vadis?
    Nähle CP; Düsing R; Schild H
    Rofo; 2015 Apr; 187(4):237-47. PubMed ID: 25629384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal denervation therapy for the treatment of resistant hypertension: a position statement by the Canadian Hypertension Education Program.
    Khan NA; Herman RJ; Quinn RR; Rabkin SW; Ravani P; Tobe SW; Feldman RD; Wijeysundera HC; Padwal RS;
    Can J Cardiol; 2014 Jan; 30(1):16-21. PubMed ID: 24269056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effect of catheter based renal synthetic denervation on renin-angiotensin-aldosterone system in patients with resistant hypertension].
    Wang L; Lu CZ; Zhang X; Luo D; Zhao B; Yu X; Xia DS; Chen X; Zhao XD
    Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Jan; 41(1):3-7. PubMed ID: 23651959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy of catheter-based renal denervation in mongrel neurogenic hypertensive dogs].
    Lu CZ; Liu J; Xia DV; Zhao XD; Chen X; Yu X; Xu JQ; Zhang J; Pan L; Liu SY; Wang L
    Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Jan; 40(1):14-7. PubMed ID: 22490627
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.